Thrombosis

Award-winning partnership proves Vocantas CallAssure effective tool for chronic disease management

Published in Hospital Law Weekly, May 14th, 2009

Vocantas Inc., a developer of automated telephone outreach solutions, announced the sale of its CallAssure solution to The Ottawa Hospital to manage patients in its Thrombosis Program.

This comes as a new study published in the Canadian Medical Association Journal shows that CallAssure was effective in helping The Ottawa Hospital keep thrombosis patients in the proper dosing range an impressive 80 percent of the time. In addition the clinic experienced a 33 percent reduction in staff workload. The purchase and full-time deployment of CallAssure may ultimately allow The Ottawa Hospital Thrombosis Program to efficiently and effectively manage the blood thinners of more...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital Law Weekly

Source: Hospital Law Weekly (2009-05-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry